Intravenous Iron May Increase Depression Among Hemodialysis Patients

Last updated: May 16, 2017
Sponsor: Benha University
Overall Status: Completed

Phase

N/A

Condition

Anemia

Depression

Treatment

N/A

Clinical Study ID

NCT03157050
BN-13058
  • Ages > 19
  • All Genders

Study Summary

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. age was above 19 years,

  2. patient on maintenance hemodialysis,

  3. patient had iron deficiency anemia (ferritin > 100 ng/ml)

Exclusion

Exclusion Criteria:

  1. patient has history of depression or already using antidepressant medication,

  2. Lack of ferritin level increase ≥ 50% from baseline level before IV ironadministration,

  3. patient already on oral or intravenous iron supplement

Study Design

Total Participants: 112
Study Start date:
January 14, 2016
Estimated Completion Date:
May 16, 2017